Nano‐bio Interface and Intrinsic Bioactivity of Biomimetic Nanoparticles: Dr. Ennio Tasciotti, Ph.D, Associate Professor of Nanomedicine, Institute for Academic Medicine, Director Center for Biomimetic Medicine
"mRNA technology is a good fit for gene editing. We want to make these editing proteins for just a short period of time to modify the genome. And producing the editing enzymes transiently helps to reduce the potential for off-target effects."